Scarica l'app Stockscreener
9.09
0.89%
0.08
Dopo l'orario di chiusura:
9.08
-0.010
-0.11%
Precedente Chiudi:
$9.01
Aprire:
$9.03
Volume 24 ore:
60,421
Relative Volume:
0.52
Capitalizzazione di mercato:
$131.06M
Reddito:
$166.88M
Utile/perdita netta:
$-74.18M
Rapporto P/E:
-1.7929
EPS:
-5.07
Flusso di cassa netto:
$1.14M
1 W Prestazione:
-1.52%
1M Prestazione:
+3.65%
6M Prestazione:
-46.09%
1 anno Prestazione:
-63.90%
Intervallo 1D:
$9.03
$9.185
Intervallo di 1 settimana:
$8.91
$9.5389
Portata 52W:
$7.8701
$26.00
Anika Therapeutics Inc Stock (ANIK) Company Profile
Nome
Anika Therapeutics Inc
Settore
Telefono
(781) 457-9000
Indirizzo
32 WIGGINS AVENUE, BEDFORD, MA
Confronta ANIK con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ANIK
Anika Therapeutics Inc
|
9.09 | 131.93M | 166.88M | -74.18M | 1.14M | -5.07 |
|
ZTS
Zoetis Inc
|
153.20 | 67.75B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.29 | 47.88B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.84 | 43.70B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.48 | 21.51B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
380.47 | 18.31B | 2.99B | 1.21B | 1.13B | 25.06 |
Anika Therapeutics Inc Stock (ANIK) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-17 | Iniziato | B. Riley Securities | Buy |
| 2024-11-01 | Reiterato | Barrington Research | Outperform |
| 2023-08-14 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2023-03-07 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2022-11-09 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2022-10-14 | Ripresa | Stephens | Equal-Weight |
| 2022-03-09 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2022-03-09 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2021-11-16 | Iniziato | Stephens | Overweight |
| 2021-07-16 | Iniziato | UBS | Neutral |
| 2020-12-16 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2020-05-08 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2020-01-21 | Aggiornamento | Sidoti | Neutral → Buy |
| 2020-01-10 | Aggiornamento | First Analysis Sec | Outperform → Strong Buy |
| 2019-11-05 | Iniziato | BWS Financial | Sell |
| 2019-09-24 | Reiterato | Barrington Research | Outperform |
| 2019-09-23 | Downgrade | First Analysis Sec | Strong Buy → Outperform |
| 2019-07-25 | Aggiornamento | First Analysis Sec | Neutral → Strong Buy |
| 2019-02-22 | Downgrade | First Analysis Sec | Outperform → Neutral |
| 2019-02-22 | Downgrade | Sidoti | Buy → Neutral |
| 2018-07-27 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2018-06-20 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2018-06-20 | Downgrade | First Analysis Sec | Overweight → Equal-Weight |
| 2018-05-04 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2018-02-23 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2018-01-24 | Aggiornamento | First Analysis Sec | Equal-Weight → Overweight |
| 2017-10-27 | Reiterato | Barrington Research | Outperform |
| 2016-05-09 | Aggiornamento | Singular Research | BUY - Long-Term → Buy |
| 2016-04-27 | Downgrade | Northland Capital | Outperform → Market Perform |
| 2016-02-26 | Reiterato | Barrington Research | Outperform |
Mostra tutto
Anika Therapeutics Inc Borsa (ANIK) Ultime notizie
Pomerantz LLP Investigates Potential Claims Involving Anika Therapeutics Investors - geneonline.com
Published on: 2025-09-04 09:02:32 - Newser
Will Anika Therapeutics Inc. stock recover after recent dropMarket Rally & Free Risk Controlled Daily Trade Plans - Newser
Is Anika Therapeutics Inc. stock bottoming outJuly 2025 Market Mood & Advanced Technical Analysis Signals - Newser
How hedge fund analytics apply to Anika Therapeutics Inc. stockFed Meeting & Risk Managed Investment Strategies - Newser
Sentiment analysis tools applied to Anika Therapeutics Inc.Weekly Trade Review & Daily Chart Pattern Signal Reports - Newser
Does Anika Therapeutics Inc. have declining or rising EPSJuly 2025 Summary & Consistent Return Strategy Ideas - khodrobank.com
Live market analysis of Anika Therapeutics Inc.Market Performance Recap & Verified Technical Trade Signals - Newser
Is Anika Therapeutics Inc. gaining market shareBreakout Watch & Fast Entry and Exit Trade Plans - khodrobank.com
Risk adjusted return profile for Anika Therapeutics Inc. analyzedTrade Volume Summary & Consistent Profit Alerts - Newser
What data driven models say about Anika Therapeutics Inc.’s futureLong Setup & Consistent Income Trade Ideas - Newser
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc.ANIK - cnhinews.com
Will Anika Therapeutics Inc. rebound enough to break evenWeekly Volume Report & High Conviction Buy Zone Picks - Newser
Real time breakdown of Anika Therapeutics Inc. stock performanceSell Signal & Daily Growth Stock Investment Tips - Newser
Visual analytics tools that track Anika Therapeutics Inc. performanceJuly 2025 Breakouts & Weekly Watchlist of Top Performers - Newser
Statistical indicators supporting Anika Therapeutics Inc.’s strengthWeekly Gains Report & Weekly Watchlist for Hot Stocks - Newser
How institutional ownership impacts Anika Therapeutics Inc. stock2025 Stock Rankings & Community Trade Idea Sharing Platform - Newser
Will Anika Therapeutics Inc. price bounce be sustainableWeekly Trade Report & Free Safe Capital Growth Stock Tips - Newser
Is Anika Therapeutics Inc. stock entering bullish territoryMarket Movers & Advanced Swing Trade Entry Plans - Newser
Will Anika Therapeutics Inc. benefit from geopolitical trendsInsider Selling & Daily Profit Focused Screening - khodrobank.com
Real time scanner hits for Anika Therapeutics Inc. explainedQuarterly Market Review & Smart Allocation Stock Tips - Newser
Tools to monitor Anika Therapeutics Inc. recovery probabilityJuly 2025 Recap & Expert Curated Trade Ideas - Newser
Is Anika Therapeutics Inc. forming a bottoming base2025 Winners & Losers & Long-Term Growth Plans - Newser
Tick level data insight on Anika Therapeutics Inc. volatility2025 Stock Rankings & Real-Time Volume Triggers - Newser
Understanding Anika Therapeutics Inc.’s price movementJuly 2025 Trends & Low Risk Profit Maximizing Plans - Newser
Using fundamentals and technicals on Anika Therapeutics Inc.2025 Historical Comparison & Free Expert Approved Momentum Trade Ideas - Newser
Can a trend reversal in Anika Therapeutics Inc. lead to recoveryWeekly Risk Report & Trade Opportunity Analysis Reports - Newser
Applying Wyckoff theory to Anika Therapeutics Inc. stockPortfolio Profit Report & Free Community Consensus Stock Picks - Newser
Aug Ideas: What are Anika Therapeutics Inc.’s technical support levels - khodrobank.com
What are Anika Therapeutics Inc.’s recent SEC filings showing2025 Market WrapUp & Weekly Consistent Profit Watchlists - khodrobank.com
Can you recover from losses in Anika Therapeutics Inc.Market Rally & Weekly Top Stock Performers List - Newser
Will Anika Therapeutics Inc. outperform the market in YEARJuly 2025 Opening Moves & Stepwise Trade Signal Guides - khodrobank.com
How to integrate Anika Therapeutics Inc. into portfolio analysis toolsJuly 2025 PreEarnings & Risk Controlled Daily Plans - Newser
Pomerantz LLP Investigates Anika Therapeutics Securities Fraud Claims - AInvest
What is the target price for Anika Therapeutics Inc. stockFed Meeting & Weekly Setup with ROI Potential - khodrobank.com
Can Anika Therapeutics Inc. expand into new marketsMarket Performance Recap & Daily Price Action Insights - khodrobank.com
How to forecast Anika Therapeutics Inc. trends using time series2025 Technical Overview & Smart Investment Allocation Tips - Newser
Anika Therapeutics Inc. Hits Oversold Level on RSI Indicator getLinesFromResByArray error: size == 0 - kangso.co.kr
Technical analysis overview for Anika Therapeutics Inc. stockPortfolio Update Summary & Real-Time Chart Pattern Alerts - Newser
Regression analysis insights on Anika Therapeutics Inc. performance2025 Volume Leaders & Low Risk High Win Rate Stock Picks - Newser
Growth Review: What are Anika Therapeutics Inc.’s technical support levels2025 Price Momentum & Real-Time Volume Analysis - khodrobank.com
Anika Therapeutics Inc. Hits Oversold Level on RSI Indicator2025 Bull vs Bear & Verified Trade Idea Suggestions - beatles.ru
Anika Therapeutics Inc Azioni (ANIK) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Anika Therapeutics Inc Azioni (ANIK) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Nunes Anne | SVP, Chief Operations Officer |
Mar 17 '25 |
Option Exercise |
0.00 |
3,637 |
0 |
21,722 |
| Colleran David | EVP, General Counsel, Corp Sec |
Mar 17 '25 |
Option Exercise |
0.00 |
6,448 |
0 |
49,847 |
| Blanchard Cheryl R | President, CEO, Director |
Mar 17 '25 |
Option Exercise |
0.00 |
25,132 |
0 |
209,472 |
| Nunes Anne | SVP, Chief Operations Officer |
Mar 11 '25 |
Option Exercise |
0.00 |
2,561 |
0 |
18,837 |
| Colleran David | EVP, General Counsel, Corp Sec |
Mar 11 '25 |
Option Exercise |
0.00 |
7,663 |
0 |
45,649 |
| Blanchard Cheryl R | President, CEO, Director |
Mar 11 '25 |
Option Exercise |
0.00 |
30,060 |
0 |
197,015 |
| Nunes Anne | SVP, Chief Operations Officer |
Mar 10 '25 |
Option Exercise |
0.00 |
3,296 |
0 |
17,235 |
| Colleran David | EVP, General Counsel, Corp Sec |
Mar 10 '25 |
Option Exercise |
0.00 |
5,465 |
0 |
39,590 |
| Blanchard Cheryl R | President, CEO, Director |
Mar 10 '25 |
Option Exercise |
0.00 |
20,002 |
0 |
172,826 |
| Nunes Anne | SVP, Chief Operations Officer |
Oct 01 '24 |
Option Exercise |
0.00 |
2,491 |
0 |
14,211 |
3.60%
0.69%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):